Stroke Prevention in Atrial Fibrillation The Role of Oral Anticoagulation

被引：14
作者：
Mtwesi, Viwe [1 ]
Amit, Guy [1 ]
机构：
[1] McMaster Univ, Hamilton Gen Hosp, Dept Med, Div Cardiol, 237 Barton St East, Hamilton, ON L8L 2X2, Canada
来源：
MEDICAL CLINICS OF NORTH AMERICA | 2019年 / 103卷 / 05期
关键词：
Atrial fibrillation; Stroke prevention; Anticoagulation; NOAC; Warfarin; DIRECT-CURRENT CARDIOVERSION; PREDICTING STROKE; ISCHEMIC-STROKE; ELECTRICAL CARDIOVERSION; RISK STRATIFICATION; TREATED PATIENTS; DIRECT THROMBIN; LOW-INTENSITY; PLUS ASPIRIN; WARFARIN;
D O I：
10.1016/j.mcna.2019.05.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Oral anticoagulation significantly reduces the risk of stroke in patients with atrial fibrillation (AF), and the decision to initiate therapy is based on assessing the patient's yearly risk of stroke. Although warfarin remains the drug of choice in patients with AF and artificial mechanical valves, the novel anticoagulation agents are becoming the drug of choice for all other patients with AF, because of their efficacy, safety, and ease of use. This article summarizes the current evidence for stroke prevention in AF, including valvular AF, subclinical AF, AF in patients with renal insufficiency, as well as stroke prevention around AF cardioversion.
引用
收藏
页码：847 / +
页数：17
相关论文
共 83 条
  • [1] Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690
  • [2] [Anonymous], 2015, J Thromb Haemost, V13 Suppl 2, P1, DOI 10.1111/jth.12993
  • [3] [Anonymous], 2014, J AM HEART ASS
  • [4] ROLE OF PROPHYLACTIC ANTICOAGULATION FOR DIRECT-CURRENT CARDIOVERSION IN PATIENTS WITH ATRIAL-FIBRILLATION OR ATRIAL-FLUTTER
    ARNOLD, AZ
    MICK, MJ
    MAZUREK, RP
    LOOP, FD
    TROHMAN, RG
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (04) : 851 - 855
  • [5] High Rate of Magnetic Resonance Imaging Stroke Recurrence in Cryptogenic Transient Ischemic Attack and Minor Stroke Patients
    Bal, Simerpreet
    Patel, Shiel K.
    Almekhlafi, Mohammed
    Modi, Jayesh
    Demchuk, Andrew M.
    Coutts, Shelagh B.
    [J]. STROKE, 2012, 43 (12) : 3387 - 3388
  • [6] Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: A retrospective analysis
    Berger, M
    Schweitzer, P
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (12) : 1545 - +
  • [7] Blackshear JL, 1996, LANCET, V348, P633
  • [8] Outpatient cardioversion of atrial arrhythmias: Efficacy, safety, and costs
    Botkin, SB
    Dhanekula, LS
    Olshansky, B
    [J]. AMERICAN HEART JOURNAL, 2003, 145 (02) : 233 - 238
  • [9] Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]
  • [10] Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation
    Cappato, Riccardo
    Ezekowitz, Michael D.
    Klein, Allan L.
    Camm, A. John
    Ma, Chang-Sheng
    Le Heuzey, Jean-Yves
    Talajic, Mario
    Scanavacca, Mauricio
    Vardas, Panos E.
    Kirchhof, Paulus
    Hemmrich, Melanie
    Lanius, Vivian
    LingMeng, Isabelle
    Wildgoose, Peter
    van Eickels, Martin
    Hohnloser, Stefan H.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 (47) : 3346 - 3355
123456789